摘要
In the past several years,nanopore sequencing technology from Oxford Nanopore Technologies(ONT)and single-molecule real-time(SMRT)sequencing technology from Pacific BioSciences(PacBio)have become available to researchers and are currently being tested for cancer research.These methods offer many advantages over most widely used high-throughput short-read sequencing approaches and allow the comprehensive analysis of transcriptomes by identifying full-length splice isoforms and several other posttranscriptional events.In addition,these platforms enable structural variation characterization at a previously unparalleled resolution and direct detection of epigenetic marks in native DNA and RNA.Here,we present a comprehensive summary of important applications of these technologies in cancer research,including the identification of complex structure variants,alternatively spliced isoforms,fusion transcript events,and exogenous RNA.Furthermore,we discuss the impact of the newly developed nanopore direct RNA sequencing(RNA-Seq)approach in advancing epitranscriptome research in cancer.Although the unique challenges still present for these new singlemolecule long-read methods,they will unravel many aspects of cancer genome complexity in unprecedented ways and present an encouraging outlook for continued application in an increasing number of different cancer research settings.
基金
the National Natural Science Foundation of China(82172937,81972247,81930123 and 81790252)。
